1. Home
  2. RYM vs TIL Comparison

RYM vs TIL Comparison

Compare RYM & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RYM

RYTHM Inc.

N/A

Current Price

$24.72

Market Cap

60.2M

ML Signal

N/A

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$8.10

Market Cap

54.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYM
TIL
Founded
2016
2018
Country
United States
United States
Employees
141
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.2M
54.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
RYM
TIL
Price
$24.72
$8.10
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
6.5K
30.5K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
6.06
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.00
$5.67
52 Week High
$53.65
$42.75

Technical Indicators

Market Signals
Indicator
RYM
TIL
Relative Strength Index (RSI) 43.87 48.05
Support Level $24.33 $7.95
Resistance Level $30.35 $8.29
Average True Range (ATR) 1.51 0.17
MACD -0.41 0.02
Stochastic Oscillator 9.93 51.35

Price Performance

Historical Comparison
RYM
TIL

About RYM RYTHM Inc.

Rythm Inc is a USA Based company. The company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: